Abbott Laboratories vs. Wave Life Sciences Ltd. Ordinary Shares
Abbott Laboratories (ABT) comes out ahead, leading on 7 of 8 compared factors.
Size & Scale
| ABT | WVE | |
|---|---|---|
| Market Cap | $187.95 billion | $994.11 million |
| Revenue (TTM) | $46.59 billion | $65.37 million |
| Net Income (TTM) | $5.42 billion | $-202,473,000 |
ABT leads on 3 of 3 size & scale factors.
Valuation
| ABT | WVE | |
|---|---|---|
| P/E Ratio | 35.51 | — |
| Price / Book | 3.63 | 2.19 |
| Price / Sales | 4.03 | 15.21 |
ABT and WVE split the valuation factors evenly.
Profitability
| ABT | WVE | |
|---|---|---|
| Net Margin | 11.65% | -309.73% |
| Return on Equity | 10.48% | -44.64% |
ABT leads on 2 of 2 profitability factors.
Dividend
| ABT | WVE | |
|---|---|---|
| Dividend Yield | 2.30% | — |
| Payout Ratio | 81.55 | — |
ABT and WVE split the dividend factors evenly.
Risk & Sentiment
| ABT | WVE | |
|---|---|---|
| Short Interest | 0.57% | 1.22% |
ABT leads on 1 of 1 risk & sentiment factors.
Dig deeper: ABT overview, ABT financials, WVE overview, WVE financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.